Mylan recalls
FDA enforcement reports naming Mylan LLC. as the recalling firm.
- Recall reports
- 5
- Class I (serious)
- 0
- Most recent report
- Feb 1, 2017
- Feb 1, 2017Temozolomide Capsules, 100 mg, packaged in a) 5-count bottles (NDC 0378-5262-98), b) 14…Drug · Mylan LLC.Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Class II
- Feb 1, 2017Temozolomide Capsules, 140 mg, packaged in a) 5-count bottles (NDC 0378-5263-98), b) 14…Drug · Mylan LLC.Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Class II
- Feb 1, 2017Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98), b) 14…Drug · Mylan LLC.Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Class II
- Feb 1, 2017Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, IncDrug · Mylan LLC.Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.Class II
- Dec 5, 2012Mylan, Tacrolimus Capsules 0Drug · Mylan LLC.Failed USP Content Uniformity Requirements: OOS result reported on retained samples.Class II